Oragenics, Inc. (NYSE: OGEN) today announced that it has commenced a proposed underwritten public offering of common stock of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE